What is Circadiance?
Circadiance is at the forefront of respiratory care innovation, focusing on remote patient monitoring solutions that bridge the gap between healthcare professionals and patients globally. Their cloud-based platform is designed to enhance patient care, particularly for premature infants, enabling them to transition home sooner while offering substantial time and cost savings to hospitals and homecare providers. The company's product suite includes advanced Positive Airway Pressure (PAP) devices tailored for individuals with sleep-disordered breathing and NICU patients requiring non-invasive ventilation. Circadiance's strategic focus is on equipping healthcare institutions and professionals with cutting-edge monitoring technologies to elevate the standard of care.
How much funding has Circadiance raised?
Circadiance has raised a total of $915K across 2 funding rounds:
Debt
$765K
Debt
$150K
Debt (2015): $765K, investors not publicly disclosed
Debt (2020): $150K led by PPP
What's next for Circadiance?
With the recent major strategic investment, Circadiance is poised for significant expansion and technological advancement. The company's focus on remote patient monitoring in respiratory care aligns with the global trend towards telehealth and proactive health management. This backing will likely fuel further research and development into their PAP devices and cloud-based solutions, potentially expanding their market reach into new territories or patient demographics. The strategic nature of this financing suggests a focus on scaling operations, enhancing product capabilities, and solidifying partnerships within the healthcare ecosystem to further improve patient outcomes and provider efficiency.
See full Circadiance company page
